Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05875649

A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure

Sponsor: Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

Summary

Most of patients with acute myeloid leukemia achieved complete remission (CR) after primary induction chemotherapy, there were 20-30% patients without CR after first-induction. It was uncertain how to treat these patients. It was investigated in our study that these patients were re-induced with CLAG Regimen. The CR ratio, overall survival (OS) and relapsed-free survival (RFS) was statistically analysed in these patients.

Key Details

Gender

All

Age Range

14 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

137

Start Date

2023-07-02

Completion Date

2027-12-20

Last Updated

2023-07-05

Healthy Volunteers

No

Conditions

Interventions

COMBINATION_PRODUCT

CLAG

Acute myeloid leukemia patients are re-induced by CLAG Regimen after first-induction failure

Locations (2)

Nanfang Hospital of Southern Medical University

Guanzhou, Guangdong, China

Nanfang Hospital of Southern Medical University

Guanzhou, Guangdong, China